While transcriptional control mechanisms of innate immune gene expression are well characterized, almost nothing is known about how pre-mRNA splicing decisions influence, or are influenced by, macrophage activation. Here, we demonstrate that the splicing factor hnRNP M is a critical repressor of innate immune gene expression and that its function is regulated by pathogen sensing cascades. Loss of hnRNP M leads to hyperinduction of a unique regulon of inflammatory and antimicrobial genes, including IL6, Mx1, and Gbp5, following a variety of innate immune stimuli. While mutating specific serines on hnRNP M had little effect on its ability to control pre-mRNA splicing or transcript levels of "housekeeping" genes in resting macrophages, it greatly impacted the protein's ability to dampen induction of specific innate immune transcripts following activation of pathogen sensing cascades. These data reveal a previously unappreciated role for pattern recognition receptor signaling in controlling splicing factor phosphorylation and establish pre-mRNA splicing as a critical regulatory node in defining innate immune outcomes.
When innate immune cells like macrophages sense pathogens, they undergo a massive reprogramming of gene-expression. Decades of research have described the transcription factors and signal transduction cascades that initiate transcription of innate immune defense molecules. However, the contribution of post-transcriptional regulatory events and pre-mRNA splicing decisions to innate immune outcomes during macrophage activation remains understudied.
Multiple lines of evidence support a crucial role for pre-mRNA splicing regulation in determining innate immune gene expression outcomes. When primary mouse macrophages are treated with a Toll-like receptor 4 (TLR4) agonist to activate innate immune gene expression, individual transcripts show significant variation in the time it takes for them to be fully spliced, with some pre-mRNAs remaining unprocessed for hours after transcriptional activation 1,2 .
Likewise, computational analyses of human primary macrophages reveal a robust increase in mRNA isoform diversity and a global preference for exon inclusion following lipopolysaccharide (LPS) treatment or Salmonella enterica serovar Typhimurium infection 3 . The production of functionally diverse protein isoforms via alternative splicing is also known to influence innate immune responses. Several important innate immune molecules downstream of pattern recognition receptors, such as the TLR adapter protein MyD88 4 , the interleukin-1 receptor associated kinase 1, IRAK1 5 , and even some of the TLRs themselves (TLR3, TLR4 co-receptor MD2) 6, 7 , are regulated through expression of truncated isoforms that auto-inhibit full length protein function and dampen inflammatory responses. In the case of MyD88, splicing factors like SF3a1 have been directly implicated in generating the MyD88 short isoform (MyD88-S), which inhibits expression of pro-inflammatory cytokines like interleukin-6 (IL-6) following LPS treatment 8, 9 . Despite these and other lines of evidence pointing to an important role for splicing and alternative splicing in controlling innate immune outcomes, little is known about how splicing decisions are regulated in innate immune cells undergoing gene expression reprogramming.
To date, a handful of RNA binding proteins (RBPs) have a characterized role in controlling innate immune gene expression, and in some cases, innate immune signaling has been connected to RBP function. For example, TLR4 signaling via LPS treatment promotes the shuttling of hnRNP U (heterogeneous nuclear ribonucleoprotein particle U) from the nucleus to the cytosol, resulting in differential expression of several innate immune cytokines (Tnfα, IL6, and IL-1β) via hnRNP U-dependent stabilization of cytosolic mRNAs 10 . Tristetraprolin (TTP), human antigen R (HUR), T-cell intracellular antigen 1 related protein (TIAR), and hnRNP K have also been implicated in controlling gene expression in LPS-activated macrophages, with TTP and HUR regulating mRNA decay and TIAR and hnRNP K causing translational repression [11] [12] [13] .
Phosphorylation is generally thought to control subcellular localization and protein-protein interactions between these RBPs and others in the hnRNP and SR (serine-arginine rich) families [14] [15] [16] [17] [18] [19] , but the kinases/phosphatases responsible for modifying them and the conditions under which these modifications are controlled remain poorly understood.
Two recent publications report changes to macrophage protein phosphorylation following infection with the intracellular pathogens bacterium Mycobacterium tuberculosis 20 and
Cryptococcus neoformans 21 . Intriguingly, a number of these differentially phosphorylated peptides were derived from splicing factors. In fact, "spliceosome" was the top over-represented phosphorylated pathway in C. neoformans-infected cells, suggesting that post-translational modification of splicing factors is critical for controlling innate immune responses to pathogens.
One of the proteins that was significantly differentially phosphorylated in each of these datasets was hnRNP M. HnRNP M is a splicing factor and RBP that has been repeatedly implicated in cancer metastasis [22] [23] [24] [25] and muscle differentiation 26 . It has also been identified as a component of a large splicing regulatory complex containing Rbfox which controls alternative splicing in the brain 27 . Its role in regulating innate immune gene expression in macrophages is unknown, although interestingly, it is targeted by proteases from two positive strand RNA viruses (polio and coxsackievirus) in order to promote infection 28, 29 . HnRNP M has also been found to influence dengue virus replication 30 , suggesting a role in regulating host antiviral responses.
Here, we demonstrate that abrogating hnRNP M expression in a macrophage cell line leads to hyperinduction of hundreds of transcripts following distinct innate immune stimuli, including infection with the gram-negative bacteria Salmonella enterica serovar Typhimurium, treatment with TLR2 and TLR4 agonists, and transfection of cytosolic dsDNA. While our data reveal that hnRNP M co-transcriptionally represses gene expression by influencing both constitutive and alternative splicing decisions, regulation of hnRNP M's function via phosphorylation at S574 specifically controls the protein's ability to inhibit intron removal of innate immune-activated transcripts. Consistent with its role in down-regulating macrophage activation, macrophages lacking hnRNP M were better able to control viral replication, emphasizing the importance of pre-mRNA splicing regulation in modulating the innate immune response to infection.
RESULTS

RNA-SEQ analysis reveals immune response genes are regulated by hnRNP M during
Salmonella infection
To investigate a role for hnRNP M in regulating the innate immune response, we first tested how loss of hnRNP M globally influenced macrophage gene expression. Stable hnRNP M knockdown cell lines (hnRNP M KD) were generated by transducing RAW 264.7 mouse macrophages with lentiviral shRNA constructs designed to target hnRNP M or a control scramble (SCR) shRNA. Western blot and RT-qPCR analysis confirmed ~80% and 60% knockdown of hnRNP M using two different shRNA constructs (in KD1 and KD2, respectively) (Fig. 1a) . Numerous attempts to knockout hnRNP M in RAW 264.7 macrophages by CRISPR/Cas9 gRNAs resulted exclusively in clones with in-frame insertions or deletions (data not shown). Therefore, we concluded that hnRNP M is essential in macrophages and continued our experiments using the viable knockdown cell lines.
We next infected hnRNP M KD1 and SCR cell lines with Salmonella Typhimurium at an MOI of 10 and performed RNA-seq analysis on total polyA+ selected RNA collected from uninfected and infected cells at 4h post-infection. We chose 4h as a key innate immune time point as one would expect robust transcriptional activation downstream of TLR4 through both MyD88 and TRIF adapters by 4h 31 . To determine how loss of hnRNP M affected gene expression in both uninfected and Salmonella-infected RAW 264.7 macrophages, we used CLC Genomics Workbench differential expression pipeline to identify genes whose expression was regulated by hnRNP M. A number of genes were differentially expressed in uninfected hnRNP M KD cells when compared to SCR control cells, with 391 genes up-regulated and 174 downregulated ( Fig. 1b and 1c ) and similar ratios of up-and down-regulated genes were seen in hnRNP M KD cells infected with Salmonella compared to SCR control (Fig. 1d) . In both conditions (+/-Salmonella), loss of hnRNP M led to far more upregulated genes (blue) than downregulated (red), indicating that hnRNP M generally acts as a repressor of gene expression, consistent with previous reports of it repressing pre-mRNA splicing 32, 33 . Interestingly, we observed only 25% overlap between genes that were differentially expressed in uninfected and Salmonella-infected macrophages, suggesting that hnRNP M has distinct modes of operation depending on the activation state of a macrophage (Fig. S1) whose expression were dramatically affected by loss of hnRNP M (Fig. 1f) . Additional pathways enriched for hnRNP M-dependent genes can be found in Fig. S1B and a list of all impacted genes (+/-1.5 fold change) can be found in Table S1 . Tgm2  Fcgr4  Gm10260  Il10ra  Sema4a  Ccrl2  Ass1  Adgre1  Il4i1  Pik3r6  Bcl3  Tnfsf9  Fcgr1  Igsf6  Lacc1  Zc3h12c  Gngt2  Gm4070  Plk2  Bcl2a1a  Rsad2  Lsp1  Cmpk2  Fabp4  Stat5a  Napsa  Ppp1r15a  Gk  Myo1f  Gpnmb  Arhgef3  Tnfaip3  Nfkbiz  Syk  Tagap  Itgal  Mpeg1  Cebpb  Dusp2  Ctsf  Fam129a  Zfp36  Saa3  Slc44a1  Ldlr  Ptafr  Acp2  Fam177a  Birc3  Anpep  Myo1g  Tnfrsf1b  Il18  Tnfaip2  Cxcl16  Traf1  Gbp5  Blnk  Atf3  Gadd45b  Lrrc25  Jak2  Icam1   0  -8  12   d   Lif   0  -4  4   c   uninfected   Adora2a  Bcl3  C3  C3ar1  Tnfsf9  Tnfsf  Traf1  Ccrl2  Cd276  Cd300c2  Cd300e  Cd36  Cfb  Ctsc  Cxcl16  Dusp1  Fabp3  Fabp4  Fcgr1  Fcgr2b  Fcgr3  Fcgr4  Gbp5  Havcr2  Igsf6  Il10ra  Il18  Il4i1  Il6  Jak2  Marcks  Mx1  Nectin2  Nfkbiz  Pld4  Pld4  Sema4a  Siglece  Slamf9  Smpdl3a  Tgm2  Tnfaip2  Tnfaip3  Tnfrsf1b  Ccl17  Ccl2  Ccl7  Sema7a  Tnfsf15  Tnfsf8   4  -4 ( Fig. 1h and S1 ). Importantly, we found that induction of other pro-inflammatory mediators such as IL1β and Tnfα did not rely on hnRNP M (Fig. 1i) (Fig. 2b) . Importantly, hyperinduction of IL6 mRNA in both LPS-treated and Salmonella-infected hnRNP M KD macrophages increased IL-6 protein levels 3-6 fold ( Fig. 2c) , indicating that hnRNP M repression of IL6 mRNA processing impacts protein outputs in a biologically meaningful way. We believe hnRNP M mainly functions to repress IL6 expression early in macrophage activation, as we did not observe a difference in IL6 mRNA levels between SCR and hnRNP M KD at later time points post-LPS treatment (Fig. S2 ).
Consistent with our RNA-SEQ and RT-qPCR data from Salmonella-infected cells, IL1β
( Fig. 2d) and Tnfα ( (Fig. 2h) . These results hinted at a mechanism for hnRNP M-dependent repression that is independent of transcription factor specificity and is instead dependent on individual transcripts.
To more directly test the idea that hnRNP M's target specificity is at the level of the transcript itself, we tested whether these same genes (IL6 or Mx1) were hyperinduced in hnRNP M KD cells treated with a panel of innate immune agonists. Treatment with 100 ng/ml of the TLR2/1 agonist PAM3CSK4 hyperinduced IL6 expression in hnRNP M KD cells compared to SCR controls (Fig. 2f) , while Tnfα and IL1β mRNA levels remained similar (Fig. 2g) were expressed at similar levels ( Fig. 2i and 2j ). Direct engagement of the interferon receptor (IFNAR) with recombinant IFNβ also resulted in Mx1 hyperinduction in hnRNP M KD cells ( Primers were designed so as to only amplify introns that are still part of pre-mRNAs and not released intron lariats. At two hours post-LPS treatment, most of the IL6 transcripts we detected are partially processed, with intron 1 and to some extent intron 4 being preferentially removed and introns 2 and 3 being retained (Fig. 3b) . We then compared the relative abundance of IL6 Mx1, an anti-viral GTPase, was one of the three transcripts significantly impacted by loss of hnRNP M at the levels of gene expression ( Fig. 1f & 1h ) and alternative splicing (Fig. 3f) .
Specifically, MAJIQ identified an exon inclusion event of Mx1 "exon 9" that was significantly more frequent in hnRNP M KD uninfected macrophages vs SCR control uninfected macrophages (delta PSI exon 8-exon 9 = 0.703 vs. exon 8-exon 10 = 0.298) (Fig. 3g) . Inclusion of this exon 9 introduces a premature stop codon and exon 9-containing transcript isoforms of Mx1 are annotated as nonsense mediated decay targets. Therefore, the overall abundance of MX1 protein may be regulated by hnRNP M at multiple post-transcriptional processing steps,
i.e. bulk transcript abundance and proportion of functional protein-encoding transcripts. MAJIQ also reported increased exon inclusion events for Commd8, a putative transcriptional regulator, and Nmt2, an N-myristoyltransferase, and we confirmed each of these LSVs by semiquantitative RT-PCR (Fig. 3h & Fig. 3i ). Collectively, these data illustrate that hnRNP M can repress splicing of both constitutive and alternative introns, leading to distinct gene expression outcomes and protein synthesis outcomes in macrophages.
hnRNP M is enriched at the level of chromatin and at the IL6 genomic locus
To get a better understanding of how hnRNP M controls pre-mRNA splicing, we next asked where hnRNP M localized in RAW 264.7 macrophages and whether its localization changed upon TLR4 activation. Other hnRNP family members have been found to translocate to the cytoplasm in response to several different types of stimuli including Vesicular stomatitis virus (VSV) infection, osmotic shock, and inhibition of transcription 14, 41, 42 . In particular, previous reports of hnRNP U have shown that it shuttles out of the nucleus following LPS treatment of macrophages 10 , and hnRNP M itself has been shown to translocate from the nucleus to the cytoplasm during enterovirus infection of HeLa cells 10, 28 . Based on our data implicating hnRNP M in splicing, we predicted that it can function in the nucleus and indeed, several algorithms including NLS Mapper 43 and PredictProtein 44 predicted hnRNP M is a predominantly nuclear protein (NLS Mapper score 8.5/10; PredictProtein 98/100) (Fig. 4a ).
To examine hnRNP M localization, we performed immunofluorescence microscopy in uninfected macrophages using an antibody that detects endogenous hnRNP M and observed significant enrichment of hnRNP M in the nucleus (Fig. 4b) . We next treated macrophages with LPS and analyzed hnRNP M localization at various timepoints to determine how activation might alter localization, but we observed no major changes to hnRNP M localization. (Fig. 4c ).
This was true for both endogenous hnRNP M and a 3xFLAG-hnRNP M allele stably expressed in macrophages (Fig. S4) . As a control, we monitored the translocation of hnRNP U upon LPS treatment and observed nuclear to cytoplasmic translocation, consistent with previous reports (Fig. S4 ). Based on these results, we concluded that hnRNP M is a nuclear protein in 
macrophages and that LPS treatment does not trigger translocation to another cellular compartment.
We next sought to understand more precisely where in the nucleus hnRNP M was enriched since intron recognition and removal can occur at the level of chromatin, while nascent transcripts are still tethered to RNA Polymerase II 1, [45] [46] [47] , or in the nucleoplasm after pre-mRNAs have been fully transcribed and released. To this end, we performed a cellular fractionation experiment in RAW 264.7 macrophages over a time course of LPS treatment and visualized hnRNP M localization via western blot (Fig. 4d) . Consistent with our immunofluorescence experiments, we did not detect hnRNP M in the cytoplasmic fraction at any time point. However, we observed hnRNP M in both the nucleoplasm and the chromatin over the LPS treatment.
Macrophages stably expressing 3xFLAG-hnRNP M showed a similar hnRNP M distribution between the nucleoplasm and chromatin (Fig. S4 ). We did not observe significant redistribution of either endogenous or 3xFLAG-hnRNP M between the nucleoplasm and chromatin fractions upon LPS treatment ( Fig. 4c and S4 ). Together, fractionation and immunofluorescence experiments confirm that a population of hnRNP M associates with chromatin and the protein does not grossly redistribute in the cell upon LPS treatment.
hnRNP M's association with the IL6 locus is RNA dependent and controlled by TLR4 signaling
We next wanted to determine if hnRNP M's association with chromatin was specific for the genomic loci of genes whose regulation was impacted by hnRNP M (Fig. 1f) . We hypothesized that if hnRNP M repression of IL6 intron 3 removal occurs at the nascent transcript level, hnRNP M may associate with the IL6 genomic locus. To test this, we performed chromatin immunoprecipitation (ChIP)-qPCR. ChIP has been used extensively in yeast, and to some extent in mammals, as a spatiotemporal read out of splicing factor recruitment to nascent transcripts [48] [49] [50] [51] [52] . To test whether hnRNP M associated with the IL6 genomic locus, we immunoprecipitated endogenous hnRNP M from untreated macrophages and determined its association with the IL6 locus (DNA), using a series of tiling primers spaced approximately 500 bp apart (Fig. 4e) . We observed no enrichment of hnRNP M in the promoter region of IL6, consistent with it playing a mainly post-transcriptional role in IL6 processing (Fig. 4f , primer set 1). We did however, observe significant enrichment of hnRNP M at several primer sets in the IL6 gene, most notably over the intron 2-intron 3 region (Fig. 4f, primer set 4) . Previously published CLIP-seq experiments identified a GUGGUGG consensus site for hnRNP M; such a site exists in intron 2 of IL6 and several similar motifs are found in IL6 intron 3 (Fig. S4) . ChIPqPCR of histone H3, which showed clear depletion of nucleosomes around the IL6 transcription start site (primer sets 1 & 2), was performed to control for genomic DNA accessibility and/or primer set efficiency (Fig. 4g) . Together, these results reveal that hnRNP M can associate with the genomic locus of genes like IL6 whose splicing it represses, suggesting that it functions cotranscriptionally, prior to release of transcripts from RNA polymerase II.
Because hnRNP M is an RNA binding protein by definition, the next question we asked was whether its association with the IL6 genomic locus was dependent on RNA or occurred through interactions with chromatin-associated proteins. To this end, we performed another cellular fractionation experiment with and without RNase A digestion 52 . We observed a dramatic redistribution of hnRNP M from the chromatin to the nucleoplasm following addition of RNase, providing strong evidence that its association with chromatin is through RNA (Fig. 4h) . These data are consistent with a previously published screen of splicing factors where hnRNP M was found to have cell type-specific RNA-dependent chromatin association 53 . Based on these results looking at bulk chromatin, we next set out to test whether hnRNP M's association with the IL6 genomic locus was similarly RNA-dependent. We performed ChIP-qPCR as above but with an additional RNase treatment after sonication for 30 min at 37°C. RNase treatment completely abolished any enrichment of hnRNP M at the IL6 locus, confirming that its association with the IL6 gene depends on RNA (Fig. 4i) .
If hnRNP M acts as a repressor of IL6 splicing by binding to nascent transcripts at the IL6 locus, we hypothesized that this repression might be relieved upon TLR4 activation, which would allow a cell to robustly induce IL6 expression following pathogen sensing. To test this, we performed ChIP-qPCR of hnRNP M at the IL6 locus in RAW 264.7 macrophages treated with LPS for 1h. Remarkably, we observed a complete loss of hnRNP M enrichment at all primer sets along the IL6 gene body, including those over intron 2 and 3, following LPS treatment (Fig.   4j ). This result strongly links hnRNP M's ability to repress IL6 with its presence at the IL6 genomic locus and suggests that TLR4 signaling controls hnRNP M's repressor activity.
Phosphorylation of hnRNP M at S574 downstream of TLR4 activation controls its ability to repress expression of innate immune transcripts
A recently published phosphoproteomics dataset identified a number of splicing factors that were differentially phosphorylated during infection with the intracellular bacterium 20 . Because it is not a gram-negative bacterium, M. tuberculosis does not activate TLR4 via LPS, but it does express surface peptidoglycan, which is an agonist of TLR2. Having confirmed hnRNP M-dependent regulation of IL6 following treatment with a TLR2 agonist (PAM3CSK4) (Fig. 2f) , we reasoned that TLR2 activation upon M. tuberculosis infection may lead to the same changes in hnRNP M phosphorylation as would TLR4 activation during Salmonella infection. We thus leveraged the M. tuberculosis global phosphoproteomics dataset from Penn et al. 20 , identified 5 differentially phosphorylated serine residues on hnRNP M (S85, S431, S480, S574, and S636) (Fig. 5a) , and generated 3xFLAG-hnRNP M constructs with phosphomimic (SàD) or phosphodead (SàA) mutations at each of the serines. We then made stable RAW 264.7 macrophages expressing each of these alleles (Fig. 6b) Fig. 5b and 5c ). Interestingly, mutating S587, which is a repeat of the S574-containing sequence (MGANS(ph)LER), did not affect the regulation of IL6 or Mx1 (Fig. S5) , suggesting the location of these serines is critical and that phosphorylation-dependent regulation of hnRNP M is specific for select serine residues (Fig. S5 ).
Mycobacterium tuberculosis
Having implicated hnRNP M phosphorylation at S574 in controlling IL6 and Mx1 expression, we next wanted to see how phosphorylation affected transcripts whose expression in uninfected cells was higher in the absence of hnRNP M (Fig. 1g) . While we again observed elevated expression of these transcripts in the absence of hnRNP M (hnRNP M KD, grey bars), introduction of the phosphomutant alleles (S431A/D and S574A/D) had no effect on Rnf128, Rnf26, or Slc6a4 transcript levels (Fig. 5d) . Expression of these genes was similarly unaffected by the other hnRNP M phosphomutants (Fig. S5 ). Alternative splicing of Commd8 was also unaffected by any of the phophosmutants in either uninfected or Salmonella-infected cells (Fig.   5e ). Together, these data provide strong evidence that hnRNP M's ability to regulate the expression of constitutively expressed genes and/or influence alternative splicing decisions does not rely on phosphorylation at 574, whereas its role in regulating innate immune transcripts induced during infection is specifically controlled by this post-translational modification downstream of pathogen sensing.
To further examine how these phosphorylated residues contributed to hnRNP M's function at an LPS-induced gene like IL6, we first performed cellular fractionation to determine the localization of mutant alleles. We found that like wild-type hnRNP M, each hnRNP M phosphomutant was, to some extent, enriched in the chromatin in untreated cells (Fig. S5 ). Primer set/Actb Primer set/Actb Primer set/Actb However, in ChIP experiments looking specifically at the IL6 locus, the S574D phosphomimic allele displayed virtually no enrichment compared to 574A phosphodead allele, whose enrichment profile was similar to that of wild-type hnRNP M ( Fig. 5f and Fig. 4f ). Indeed, hnRNP M 574D ChIPs more closely resembled those from RNase or LPS-treated samples ( Fig. 4i and   4j ). These data point to phosphorylation of residue S574 in controlling hnRNP M's ability to cotranscriptionally repress processing of chromatin-associated IL6 pre-mRNAs.
We next sought to better understand how hnRNP M is phosphorylated at these key residues. TLR4 activation sets off a number of signaling cascades, including p38, MEK1/2 (ERK), and JNK MAP kinases. Previous reports have implicated each of these pathways in regulating IL6 expression downstream of innate immune stimuli 54 , but it is not known if these cascades control splicing factor phosphorylation. To test the role of each cascade in hnRNP Mdependent repression of IL6, we performed ChIP experiments in the presence of LPS and specific inhibitors of p38 (SB203580), JNK (SP600125), or MEK (U0126). We again observed LPS-dependent loss of hnRNP M enrichment at IL6 (primer sets 4, 5, and 6), and treatment with JNK and MEK inhibitors had no effect on hnRNP M release. However, in the presence of the p38 inhibitor, hnRNP M remained associated with the IL6 genomic locus after LPS treatment (Fig. 5h) , demonstrating that p38 signaling promotes release of hnRNP M from the IL6 genomic locus.
Lastly, to interrogate the mechanism driving IL6 hyperinduction in hnRNP M 574D-expressing cells, we asked whether IL6 intron removal was affected by expression of the phosphomutant alleles. Using the same RT-qPCR approach used in Figure 2B , we detected an increase in IL6 pre-mRNAs containing introns 2 and 3 in macrophages overexpressing a wildtype hnRNP M allele, consistent with hnRNP M slowing IL6 intron removal. Conversely, these same introns were removed more efficiently in the presence of hnRNP M 574D while no difference was observed in 574A-expressing cells (Fig. 5h) . These data strongly support a model whereby phosphorylation of hnRNP M at S574 relieves its ability to act as a splicing repressor, allowing for rapid removal of IL6 introns and uprgulation of IL6 mRNA. Together, they demonstrate a novel role for constitutive intron removal in mediating IL6 expression in macrophages. at the 8h time point (Fig. 6a) . As expected, infection with VSV, a potent activator of cytosolic RNA sensing via RIG-I/MAVS 55 , led to robust induction of Ifnβ levels in an hnRNP Mindependent fashion, as was previously observed in hnRNP M KD cells transfected with cytosolic dsDNA (Fig. 6b and 2i , respectively). Consistent with hnRNP M-dependent regulation occurring downstream of diverse immune stimuli (Fig. 2) , VSV-infected hnRNP M KD cells hyperinduced both IL6 and Mx1 ( Fig. 6c and d) .
Loss of hnRNP M enhances macrophage's ability to control viral infection
While Mx1 itself is a well-characterized anti-viral GTPase, several reports have noted that cell lines like RAW 264.7 that are derived from inbred mouse strains carry mutant, or in some cases non-functional, Mx1 alleles 56 . Therefore, to begin to predict what hnRNP Mregulated genes may be responsible for enhanced VSV restriction, we manually examined hnRNP M-regulated transcripts in our RNA-SEQ data from resting and Salmonella-infected 
Discussion
Despite the substantial impact pre-mRNA splicing has on gene expression outcomes,
little is known about how components of the spliceosome are modified and regulated during (Fig. 2 and Fig. 6 ) and hyperinduction of this regulon correlated with enhanced capacity of hnRNP M KD macrophages to control VSV replication at early time points (Fig. 6) . We propose that in While hnRNP M's ability to associate with the IL6 genomic locus via chromatin immunoprecipitation is RNA-dependent, it is conceivable that hnRNP M controls innate immune gene expression through mechanisms that are independent of direct contacts between hnRNP M and regulated transcripts. Because a number of splicing factors have been shown to impact histone markers and chromatin remodeling, it is possible that hnRNP M promotes epigenetic changes at specific target transcripts [65] [66] [67] [68] . hnRNP M may also interact with one or more lncRNAs, a number of which are regulated by TLR activation 69 and have been shown to control IL6 expresion 69, 70 . Experiments designed to identify hnRNP M-associated RNAs in uninfected and infected macrophages will provide important insights into how hnRNP M recognizes chromatin-associated target transcripts and help illuminate how pre-mRNA splicing decisions shape the innate immune transcriptome. SEM, n=3. Statistical significance was determined using two-tailed students' t test. *P < 0.05, **P < 0.01, ***P < 0.001. means ± SEM, n=3. Statistical significance was determined using two-tailed students' ttest. *P < 0.05, **P < 0.01, ***P < 0.001. (SD), n=3. Statistical significance was determined using two-tailed students' t test. *P < 0.05, **P < 0.01, ***P < 0.001, ****P < 0.0001, D was done with MAJIQ gene outputs from RNA-seq samples containing 3 biological replicates. H and i are representative of 3 biological replicates.
For exon inclusion values, n=1.
. Statistical significance was determined using two-tailed students' t test. *P < 0.05, **P < 0.01, ***P < 0.001. values representing means (SD), n=3. Statistical significance was determined using two-tailed students' t test. *P < 0.05, **P < 0.01, ***P < 0.001. [Sigma], 150 mM NaCl, protease inhibitor tablet (Thermo Fisher)) and incubated for 5 min on ice. Lysate was added to 2.5 volumes of a sucrose cushion (Lysis buffer with 24% sucrose) and centrifuged for at 14,000 rpm for 10min at 4C. The supernatant was collected and saved for cytoplasmic protein sample. The nuclear pellet was resuspended in glycerol buffer (20 mM Approximately 10% of sample was loaded for western blots.
RNase Fractionation
For nuclear lysates treated with RNase, nuclear pellets were responded in glycerol buffer.
Nuclear lysis buffer was added, and lysates were incubated on ice for 5 minutes. Samples were then divided into two samples with one receiving 1 ul of RNAse A (Thermo Fisher) per 50 ul sample and another with no RNAse A. Both were incubated at 37C for 30 mins. Lysates were then spun at 10,000rpm for 2 mins and the rest of the fractionation proceeded as described.
Gene Ontology (GO) Canonical Pathway Analysis
To determine the most affected pathways in control vs. hnRNP M knockdown RAW 264.7
macrophages, canonical pathway analysis was conducted using Ingenuity Pathway Analysis software from Qiagen Bioinformatics. Genes that were differentially expressed wth a pvalue<0.05 from our RNA-SEQ analysis were used as input from uninfected and Salmonella Typhimurium infected cells. The top hits were represented in bar graphs by z-score.
RNA isolation and qPCR analysis
For transcript analysis, cells were harvested in Trizol and RNA was isolated using Direct-zol Beads were washed 3x in with a final wash in high salt (500mM NaCl). DNA was eluted with elution buffer and rotated for 15 min at 30C. Centrifuge for 1 min at 2,000 x g and transfer the supernatant into a fresh tube. Supernatant was incubated in NaCl, RNase A (10 mg/mL) and proteinase K (20 mg/mL) and incubated at 65°C for 1 h. The DNA was purified using phenol:chloroform extraction. DNA levels were measure by RT-qPCR. Primers were designed by tiling each respective gene every 500 base pairs that were inputted into NCBI primer design.
FLAG Chromatin Immunoprecipitation
In RAW 264.7 macrophages stably expressing hnRNP M-FL and GFP-FL, ChIP was conducted as described above with minor adjustments. Lysates were incubated overnight at 4C with ANTI-FLAG M2 antibody. After washing, DNA was eluted with FLAG peptide (Sigma-Aldrich F4799)
by adding 20 ul of 5X FLAG peptide, vortexed at room temperature for 15 mins and supernatants were collected. This process was repeated a total of 3x followed by decrosslinking as described.
RNA-SEQ
Total RNA was extracted as previously described above. Preparation and sequencing of cDNA 
